OSCR stock forecast, quote, news & analysis
Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members... Show more
Why Oscar Health Inc. (OSCR) Stock Is Up +28.3% in the Last 30 Days
Key Takeaways
- OSCR shares surged 28.3% over the past 30 days, extending a powerful rally that has seen the stock more than double in the last quarter.
- The advance was fueled by strong first-quarter 2026 earnings, upward guidance revisions, and growing confidence in the company’s technology-driven healthcare model.
- Membership growth, improving medical loss ratios, and operational efficiencies have reinforced the bullish narrative.
- Analysts have raised price targets, and institutional interest has increased amid a broader rotation into healthcare and AI-enabled services.
- The stock’s momentum reflects both company-specific execution and favorable industry tailwinds.
Oscar Health Inc. (OSCR) Company Overview and Market Position
Oscar Health, Inc. is a technology-focused health insurance company that offers individual and small group plans, as well as Medicare Advantage, in select U.S. markets. The company leverages a proprietary data and technology platform to simplify the member experience, manage care, and control costs. Oscar’s model emphasizes telemedicine, digital tools, and a concierge-style member support system. Investors follow the stock for its disruptive potential in the health insurance industry and its path to sustained profitability.
Oscar Health Inc. (OSCR) Stock Price Performance: Last 30 Days vs. Quarter
Over the last 30 days, OSCR climbed from $22.23 (closing price on May 29, 2026) to $28.52 on June 30, 2026, a gain of 28.3%. The move was part of a broader uptrend that began in early April. For the full second quarter, the stock soared approximately 143%, rising from $11.73 on April 1 to $28.52 at quarter-end. The rally accelerated in mid-May following the company’s first-quarter earnings release and continued through June as positive sentiment built.
What Drove OSCR Stock Price in the Last 30 Days
The 30-day surge was driven by a combination of fundamental and technical factors. The company’s first-quarter 2026 results, reported in early May, showed better-than-expected revenue, membership growth, and a significant improvement in the medical loss ratio. Management also raised full-year guidance, signaling confidence in the trajectory toward profitability. In the weeks that followed, multiple Wall Street analysts upgraded the stock and lifted price targets, citing the company’s improving operating leverage and competitive positioning. Additionally, Oscar Health benefited from a broader market rotation into healthcare and technology-enabled services, as investors sought companies with strong growth and margin expansion stories. The stock’s breakout above key technical levels attracted momentum traders, further amplifying the move.
What Drove OSCR Stock Performance Over the Last Quarter
The quarterly performance was shaped by a dramatic shift in investor perception. After trading below $12 in early April, Oscar Health’s stock began to recover as the market anticipated a strong earnings report. The actual Q1 results, released on May 5, acted as a major catalyst, confirming that the company’s turnaround strategy was gaining traction. Membership additions in the individual and small group segments exceeded forecasts, while cost-control measures led to a lower medical loss ratio. The company also highlighted progress in its AI-driven care navigation tools, which resonated with the growing enthusiasm for artificial intelligence in healthcare. Throughout May and June, the stock continued to climb as institutional investors increased positions and short sellers covered. The quarterly gain of over 140% made OSCR one of the top-performing healthcare stocks in the period.
Trending AI Robots
Tickeron’s Trending AI Robots page showcases a curated selection of top-performing AI-powered trading bots from a universe of hundreds of bots that trade thousands of tickers. These bots employ diverse strategies, timeframes, and performance metrics, and only the most relevant and consistently strong performers are featured. The page helps traders discover automated strategies that align with current market conditions. To explore the latest top AI trading bots, visit the Trending AI Robots page.
OSCR Stock Forecast Drivers: What Investors Should Watch Next
Looking ahead, key drivers for OSCR include the upcoming second-quarter 2026 earnings report, where investors will assess whether membership growth and margin improvements are sustainable. Any updates to full-year guidance, particularly around profitability timelines and medical cost trends, will be critical. Macroeconomic factors such as interest rate policy, healthcare regulation, and competitive dynamics in the insurance exchanges could also influence the stock. Additionally, the company’s ability to expand its Medicare Advantage footprint and further integrate AI tools will be closely monitored. While the recent rally has been impressive, the stock’s elevated valuation multiples mean that any disappointment could lead to sharp pullbacks.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
OSCR in +12.83% Uptrend, growing for three consecutive days on July 02, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where OSCR advanced for three days, in of 267 cases, the price rose further within the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on July 01, 2026. You may want to consider a long position or call options on OSCR as a result. In of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for OSCR just turned positive on July 02, 2026. Looking at past instances where OSCR's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 212 cases where OSCR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OSCR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
OSCR broke above its upper Bollinger Band on July 01, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. OSCR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.171) is normal, around the industry mean (4.972). P/E Ratio (34.550) is within average values for comparable stocks, (48.734). OSCR's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.310). OSCR's Dividend Yield (0.000) is considerably lower than the industry average of (0.019). P/S Ratio (0.588) is also within normal values, averaging (0.653).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OSCR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock better than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry ManagedHealthCare